• Res-01
  • RESEARCH

Research Projects  

  • S.No

    Project Title

    Duration

    Funding agency

    Amount

    2017-18

    1

    Binding kinetic and structural implications in inhibition of sHER2 d-III & d-II in association with Pertzumumab structural study

    2016-19

    SERB

    24,18,000

    2

    Structural insights to inhibit Epidermal Growth Factor Receptor (EGFR) dimerization & activation: Panitumumab induced Conformational study

    2015-18

    DBT

    23,75,420

    3

    Effect of O-Sialylation on Epidermal Growth factor receptor (EGFR) mediated homo/hetero dimerization (EGFR/HER2) and activation in lung cancer cells

    2017-20

    DHR(ICMR), Sanctioned

    31,00,000

    4

    Nitric oxide donating acridones as inhibitors of doxorubicin efflux in cancer cells and their membrane perturbing studies

    2017-20

    ICMR, Sanctioned

    20,50,000

    2016-17

    5

    Role of individual isoforms of Phosphoinositide 3-kinase (PI3K) inhibitors and non-selective inhibitors in in vivo models of Alzheimer's disease (AD).

    2014-17

    DST

    8,00,000

    6

    Structural insights to inhibit Epidermal Growth Factor Receptor (EGFR) dimerization & activation: Panitumumab induced Conformational study

    2015-18

    DBT

    11,50,000

    7

    Optimization and evaluation of prazosin floating microspheres using response surface methodology

    2014-17

    DST

    7,20,000

    8

    Formulation evaluation and optimization of floating drug delidery system of antihypertensive drugs.

    2014-17

    DST

    8,20,000

    9

    Neuroprotective activity of polyherbal formulation aganist transient global ischemia induced brain damage in normal and alloxan induced diabetic rats

    2014-17

    DST

    8,10,000

    2015-16

    10

    Structural insights to inhibit Epidermal Growth Factor Receptor (EGFR)   Dimerization & Activation: Panitumumab induced conformational study.

    2015-18

    DBT

    16,65,480

    11

    Role of individual isoforms of Phosphoinositide 3-kinase (PI3K) inhibitors and non-selective inhibitors in in vivo models of Alzheimer's disease (AD).

    2014-17

    DST

    14,50,000

    12

    Design and synthesis of quinoline tagged acridones as reverters of multidrug resistance (MDR) in cancer

    2012-15

    AICTE

    3,00,000

    13

    Design and Synthesis of Nitric Oxide Donating Phenoxazine Derivatives as Reverters of Multidrug Resistance (MDR) in Cancer cells

    2012-15

    SERB

    4,50,000

    14

    Optimization and evaluation of prazosin floating microspheres using response surface methodology

    2014-17

    DST

    7,00,000

    15

    Formulation evaluation and optimization of floating drug delidery system of antihypertensive drugs.

    2014-17

    DST

    5,00,000

    16

    Neuroprotective activity of polyherbal formulation aganist transient global ischemia induced brain damage in normal and alloxan induced diabetic rats

    2014-17

    DST

    8,10,000

    17

    Projects under Institute - Industry Innovation Cell (IIIC)

    2013-15

    MSME

    1,25000